Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
Titel:
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
Auteur:
Castro, Mario Wenzel, Sally E Bleecker, Eugene R Pizzichini, Emilio Kuna, Piotr Busse, William W Gossage, David L Ward, Christine K Wu, Yanping Wang, Bing Khatry, Deepak B van der Merwe, René Kolbeck, Roland Molfino, Nestor A Raible, Donald G